trehalose - CISMeF

Preferred Label : trehalose;

MeSH CAS label : alpha-D-Glucopyranoside, alpha-D-glucopyranosyl;

MeSH Related Number : 99-20-7 (Trehalose);

Registry Number MeSH : 99-20-7;

MeSH annotation : called ergot sugar & mycose; do not confuse with TREHALASE;

Wikipedia link : https://en.wikipedia.org/wiki/Trehalose;

Codes EINECS : 202-739-6;

Is substance : O;

UNII : B8WCK70T7I;

InChIKey : HDTRYLNUVZCQOY-LIZSDCNHSA-N;

Details

Origin ID

D014199;

UMLS CUI

C0040815;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- trehalose [Substance BNPC]
Currated CISMeF NLP mapping
- Trehalose [NCIt concept]
Record concept(s)
- trehalose [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2-amino-3,4-dihydroxy-5-hydroxymethyl-1-cyclohexyl)glucopyranoside [MeSH Supplementary Concept]
- 2,2',3,3'-tetra-O-benzoyl-6,6'-dideoxy-4,4'-di-O-mesyl-6,6'-dithiocyanatotrehalose [MeSH Supplementary Concept]
- 2,3,6-triacyl trehalose [MeSH Supplementary Concept]
- 2,3-diacyltrehalose-2'-sulfate [MeSH Supplementary Concept]
- 3,3'-dideoxytrehalose [MeSH Supplementary Concept]
- 3,3'-diketotrehalose [MeSH Supplementary Concept]
- 3,3'-neotrehalosadiamine [MeSH Supplementary Concept]
- 3-O-benzoyl-4,6,4',6'-di-O-benzylidene-2,2'-dideoxyribotrehalose [MeSH Supplementary Concept]
- 3-amino-3-deoxyaltropyranosyl-3-amino-3-deoxyaltropyranoside [MeSH Supplementary Concept]
- 3-ketotrehalose [MeSH Supplementary Concept]
- 3-trehalosamine [MeSH Supplementary Concept]
- 4,4',6,6'-tetrachloro-4,4',6,6'-tetradeoxygalactotrehalose [MeSH Supplementary Concept]
- 4-O-(2,3-dihydroxy-3-methylbutyl)trehalose [MeSH Supplementary Concept]
- 4-azido-4-deoxy-alpha,alpha-trehalose [MeSH Supplementary Concept]
- 4-trehalosamine [MeSH Supplementary Concept]
- 6,6'-bis(2,3-dimethoxybenzoyl)-alpha,alpha-trehalose [MeSH Supplementary Concept]
- 6,6'-bis-O-(3-nonyldodecanoyl)-alpha,alpha'-trehalose [MeSH Supplementary Concept]
- 6,6'-diamino-6,6'-dideoxytrehalose [MeSH Supplementary Concept]
- 6-O-docosanoyl-alpha,alpha'-trehalose [MeSH Supplementary Concept]
- 6-O-hexacosanoyl-alpha,alpha'-trehalose [MeSH Supplementary Concept]
- 6-O-undecanoyl-alpha,beta-trehalose [MeSH Supplementary Concept]
- 6-azido-6-deoxytrehalose [MeSH Supplementary Concept]
- ET-Kyoto solution [MeSH Supplementary Concept]
- IT-Kyoto solution [MeSH Supplementary Concept]
- PFC-Kyoto solution [MeSH Supplementary Concept]
- SS 554 [MeSH Supplementary Concept]
- TR 153 [MeSH Supplementary Concept]
- TR 155 [MeSH Supplementary Concept]
- alpha,alpha-trehalose 6,6'-diphosphate [MeSH Supplementary Concept]
- brartemicin [MeSH Supplementary Concept]
- deoxytrehalose [MeSH Supplementary Concept]
- modified ET-Kyoto solution [MeSH Supplementary Concept]
- octa-o-acetyl-thiotrehalose [MeSH Supplementary Concept]
- trehalose 2-sulfate [MeSH Supplementary Concept]
- trehalose 6,6'-dipalmitate [MeSH Supplementary Concept]
- trehalose-6-phosphate [MeSH Supplementary Concept]
- trehangelin A [MeSH Supplementary Concept]
- trehangelin B [MeSH Supplementary Concept]
- trehangelin C [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Trehalose [NCIt concept]
- trehalose [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients